Recently Viewed
Clear All
IPO Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Bidding Date
09-Jul-2025 to
11-Jul-2025
Issue Size
₹27.56 Cr
Price Band
₹115 to ₹123
Allotment date
14-Jul-2025
Listing date
16-Jul-2025
Lot size
1000
No. of shares
22,41,000
Fresh issue/OFS
₹27.56 Cr /--
Established in 2019, Asston Pharmaceuticals Limited is a growing pharmaceutical and nutraceutical manufacturer focused on both domestic and export markets, especially in Africa. Operating under the brand “Asston,” the company develops and markets a broad portfolio of formulations including tablets, capsules, syrups, creams, gels, sachets, and suspensions. It caters to global demand through direct sales and contract manufacturing arrangements, supported by a WHO-GMP certified facility in Ambernath, Maharashtra. The facility maintains dedicated production zones for pharmaceuticals and nutraceuticals, producing up to 9 crore tablets monthly. Beyond manufacturing, Asston also provides formulation expertise to contract partners and oversees a robust export network spanning over 10 countries.
Category
Status
QIBs
85.8x
NIIs
261.6x
Retail
171.8x
Others
--
Total
173.4x
| Name | Price Band (Rs) | Bidding Date |
|---|---|---|
| Emiac Technologies | 93 - 98 | 27-Mar-2026 to 08-Apr-2026 |
| Safety Controls & Devices | 75 - 80 | 06-Apr-2026 to 08-Apr-2026 |
| Vivid Electromech | 528 - 555 | 25-Mar-2026 to 30-Mar-2026 |
| Amir Chand Jagdish Kumar (Exports) | 201 - 212 | 24-Mar-2026 to 27-Mar-2026 |
The issue size of Asston Pharmaceuticals is ₹27.56 Cr.
Asston Pharmaceuticals falls into Pharmaceuticals industry.
The Asston Pharmaceuticals IPO will be listed on NSE.
The open and close dates for the Asston Pharmaceuticals are 09-Jul-2025 & 11-Jul-2025.
The price band for the Asston Pharmaceuticals ipo is ₹115 to ₹123
The listing date of Asston Pharmaceuticals IPO is 16-Jul-2025.
The purpose of this IPO is to raise fresh capital.
Asston Pharmaceuticals total subscription ratio is 173.4X.
Key financial of the Asston Pharmaceuticals are:
| Asston Pharmaceuticals | FY-25 | FY-24 | FY-23 | FY-22 |
|---|---|---|---|---|
| Revenue (₹ Cr) | 25.04 | 15.59 | 6.54 | 9.6 |
| EBIT (₹ Cr) | 6.08 | 2.5 | 1.48 | -0.36 |
| Proft after Tax (₹ Cr) | 4.33 | 1.36 | 1.06 | 0.11 |
| Debt (₹ Cr) | 7.26 | 6.82 | 5.25 | 3.31 |
| Net Worth (₹ Cr) | 10.72 | 6.39 | 1.99 | 0.93 |
| RoE (%) | 40.35 | 21.28 | 53.21 | 11.9 |
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
